TY - JOUR
T1 - Age of surgery related to postoperative catch-up growth and development in children with acyanotic heart disease
AU - Nuralim, Muhammad Z.
AU - Soebroto, Heroe
AU - Irwanto, Irwanto
AU - Puruhito, Ito
N1 - Publisher Copyright:
Copyright © 2023 Edizioni Minerva Medica.
PY - 2023/6
Y1 - 2023/6
N2 - Introduction: Acyanotic congenital heart disease such as ventricular septal defect (VSD), arterial septal defect (ASD), patent ductus arteriosus (PDA) are the most common case of congenital heart disease (CHD). There were poor findings on growth and development in children with acyanotic CHD. Some studies showed that the patients found experienced short stature and malnutrition, which can alter the quality of life and the generation of the country. Definitive treatment for acyanotic CHD is surgery. However, several cases proved that only with the right timing of surgical intervention, the optimal growth of children with acyanotic CHD can be achieved. Several studies reveal that insulinlike growth factor 1 (IGF-1) become the key to growth spurt after surgery in early life. Therefore, in this article, author focused on the issue of intervention timing related to growth and development of acyanotic CHD patients. This review is expected to promote future research in order to improve the outcome and quality of life of children with acyanotic CHD. Evidence Acquisition: Literature reviewed in our study was gathered from PubMed, Google Scholar, ProQuest, and Clinical Key. We also reviewed the articles cited within the literature to broaden the search results. Evidence Synthesis: The data were extracted from 28 articles. Out of 28 articles gathered in this review, 13 articles are systematic review, and 15 articles were observational studies. Conclusions: Acyanotic congenital heart diseases are associated with decline in growth and development, related to poor perfusion to the organ related. Surgery is the most effective intervention as significant improvement occur afterward.
AB - Introduction: Acyanotic congenital heart disease such as ventricular septal defect (VSD), arterial septal defect (ASD), patent ductus arteriosus (PDA) are the most common case of congenital heart disease (CHD). There were poor findings on growth and development in children with acyanotic CHD. Some studies showed that the patients found experienced short stature and malnutrition, which can alter the quality of life and the generation of the country. Definitive treatment for acyanotic CHD is surgery. However, several cases proved that only with the right timing of surgical intervention, the optimal growth of children with acyanotic CHD can be achieved. Several studies reveal that insulinlike growth factor 1 (IGF-1) become the key to growth spurt after surgery in early life. Therefore, in this article, author focused on the issue of intervention timing related to growth and development of acyanotic CHD patients. This review is expected to promote future research in order to improve the outcome and quality of life of children with acyanotic CHD. Evidence Acquisition: Literature reviewed in our study was gathered from PubMed, Google Scholar, ProQuest, and Clinical Key. We also reviewed the articles cited within the literature to broaden the search results. Evidence Synthesis: The data were extracted from 28 articles. Out of 28 articles gathered in this review, 13 articles are systematic review, and 15 articles were observational studies. Conclusions: Acyanotic congenital heart diseases are associated with decline in growth and development, related to poor perfusion to the organ related. Surgery is the most effective intervention as significant improvement occur afterward.
KW - Child
KW - Heart diseases
KW - Postoperative care
UR - http://www.scopus.com/inward/record.url?scp=85164834781&partnerID=8YFLogxK
U2 - 10.23736/S0393-3660.23.04993-8
DO - 10.23736/S0393-3660.23.04993-8
M3 - Review article
AN - SCOPUS:85164834781
SN - 0393-3660
VL - 182
SP - 372
EP - 376
JO - Gazzetta Medica Italiana Archivio per le Scienze Mediche
JF - Gazzetta Medica Italiana Archivio per le Scienze Mediche
IS - 2
ER -